News

The Committee for Medicinal Products for Human Use (CHMP) received data on the use of duloxetine in the treatment of fibromyalgia in 1,411 patients in four placebo-controlled studies

The research confirmed, at the genomic level, that the immune system response to the virus, and not the virus by itself, results in common cold symptoms. Data generated

Astellas’s European subsidiary, Astellas Pharma Europe BV, previously submitted the marketing authorization application (MAA) for telavancin for complicated skin and soft tissue infections (cSSTI) in adults to the

The new data indicate that patients who continued to receive denufosol for an additional 24 weeks during the open-label extension experienced a progressive improvement in forced expiratory volume

According to the company, the median number of aura attacks was reduced by 68% (p=0.01) in patients receiving tonabersat when compared with placebo. This result in the primary

The supplemental new drug application (sNDA) submission is supported by a Phase III single-blinded controlled study conducted in Japanese women with no or irregular ovulation, including polycystic ovary

BioCancell is a biopharmaceuticals corporation specializing in the development of patient-oriented, targeted therapy for the treatment of numerous types of cancer. Products under the agreement will be manufactured

The filing is supported by data from three placebo-controlled clinical trials in patients with epilepsy. Previously, Johnson & Johnson Pharmaceutical Research & Development (J&JPRD) and SK Holdings have

Third quarter 2008 net sales from continuing operations were $5.3 billion, an increase of 14%, including a 3% favorable foreign exchange impact, as compared to the corresponding quarter